Latest news
The Merger Paradox: Why Transformational Mergers Create Extraordinary Value and Frequently Fail - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 10:07:38 GMTThe Week in Health: Pharma Mega-Merger Talks, Hospital Push - Mexico Business NewsMexico Business News · Thu, 06 Aug 2026 22:33:33 GMTMergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 10:02:44 GMTSource Denies AstraZeneca-Bristol Myers Merger Talks | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 19:02:42 GMTBeyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 15:17:36 GMT‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 14:12:01 GMT$1.8bn merger unites Supernus and Indivior in CNS therapeutics play - BioXconomyBioXconomy · Tue, 04 Aug 2026 16:38:23 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMT